These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30711400)

  • 41. Does the cerebral cortex exacerbate dopaminergic cell death in the substantia nigra of 6OHDA-lesioned rats?
    Luquin N; Mitrofanis J
    Parkinsonism Relat Disord; 2008; 14(3):213-23. PubMed ID: 18029221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental area.
    Hether S; Misono K; Lessard A
    Neuroscience; 2013 Sep; 247():12-24. PubMed ID: 23673279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor for Advanced Glycation End Products (RAGE) is Expressed Predominantly in Medium Spiny Neurons of tgHD Rat Striatum.
    Shi D; Chang JW; Choi J; Connor B; O'Carroll SJ; Nicholson LFB; Kim JH
    Neuroscience; 2018 Jun; 380():146-151. PubMed ID: 29625216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons.
    Castelli MP; Spiga S; Perra A; Madeddu C; Mulas G; Ennas MG; Gessa GL
    Neuroscience; 2016 Sep; 332():130-9. PubMed ID: 27365174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington's disease.
    Puginier E; Bharatiya R; Chagraoui A; Manem J; Cho YH; Garret M; De Deurwaerdère P
    Neurochem Int; 2019 Sep; 128():186-195. PubMed ID: 31054882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Masilamoni GJ; Groover O; Smith Y
    Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease.
    Kirch RD; Meyer PT; Geisler S; Braun F; Gehrig S; Langen KJ; von Hörsten S; Nikkhah G; Cassel JC; Döbrössy MD
    Behav Brain Res; 2013 Feb; 239():15-26. PubMed ID: 23137697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K; Czyrak A; Maćkowiak M; Fijał K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease.
    Nicholson LF; Faull RL; Waldvogel HJ; Dragunow M
    Neuroscience; 1995 Jun; 66(3):507-21. PubMed ID: 7644016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.
    Zhang J; Götz S; Vogt Weisenhorn DM; Simeone A; Wurst W; Prakash N
    Neurobiol Dis; 2015 Oct; 82():32-45. PubMed ID: 26049140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area.
    Prisco S; Esposito E
    Br J Pharmacol; 1995 Sep; 116(2):1923-31. PubMed ID: 8528581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
    Cragg S; Rice ME; Greenfield SA
    J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats.
    Pioli EY; Meissner W; Sohr R; Gross CE; Bezard E; Bioulac BH
    Neuroscience; 2008 Jun; 153(4):1213-24. PubMed ID: 18455318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson's Disease.
    Viereckel T; Dumas S; Smith-Anttila CJ; Vlcek B; Bimpisidis Z; Lagerström MC; Konradsson-Geuken Å; Wallén-Mackenzie Å
    Sci Rep; 2016 Oct; 6():35203. PubMed ID: 27762319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sex-specific disruption of murine midbrain astrocytic and dopaminergic developmental trajectories following antenatal GC treatment.
    McArthur S; Pienaar IS; Siddiqi SM; Gillies GE
    Brain Struct Funct; 2016 Jun; 221(5):2459-75. PubMed ID: 25944572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons.
    Bifsha P; Balsalobre A; Drouin J
    Mol Neurobiol; 2017 Sep; 54(7):4921-4935. PubMed ID: 27514757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesocortical Dopamine Phenotypes in Mice Lacking the Sonic Hedgehog Receptor Cdon.
    Verwey M; Grant A; Meti N; Adye-White L; Torres-Berrío A; Rioux V; Lévesque M; Charron F; Flores C
    eNeuro; 2016; 3(3):. PubMed ID: 27419218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nigral involvement and nigrostriatal dysfunction in Huntington's disease: evidences from an MRI and SPECT study.
    Kiferle L; Mazzucchi S; Unti E; Pesaresi I; Fabbri S; Nicoletti V; Volterrani D; Cosottini M; Bonuccelli U; Ceravolo R
    Parkinsonism Relat Disord; 2013 Sep; 19(9):800-5. PubMed ID: 23769177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential Somatic Ca2+ Channel Profile in Midbrain Dopaminergic Neurons.
    Philippart F; Destreel G; Merino-Sepúlveda P; Henny P; Engel D; Seutin V
    J Neurosci; 2016 Jul; 36(27):7234-45. PubMed ID: 27383597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.